TY - JOUR AU - O’Duffy, J. D. PY - 1994 DA - 1994// TI - Behcet’s disease JO - Curr Opin Rheumatol VL - 6 UR - https://doi.org/10.1097/00002281-199401000-00007 DO - 10.1097/00002281-199401000-00007 ID - O’Duffy1994 ER - TY - JOUR AU - Iwata, S. AU - Saito, K. AU - Yamaoka, K. AU - Tsujimura, S. AU - Nawata, M. AU - Hanami, K. PY - 2011 DA - 2011// TI - Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero- Behcet’s disease JO - Mod Rheumatol VL - 21 UR - https://doi.org/10.3109/s10165-010-0370-y DO - 10.3109/s10165-010-0370-y ID - Iwata2011 ER - TY - JOUR AU - Iwata, S. AU - Saito, K. AU - Yamaoka, K. AU - Tsujimura, S. AU - Nawata, M. AU - Suzuki, K. PY - 2009 DA - 2009// TI - Effects of anti-TNF-alpha antibody infliximab in refractory entero- Behcet’s disease JO - Rheumatology VL - 49 UR - https://doi.org/10.1093/rheumatology/kep126 DO - 10.1093/rheumatology/kep126 ID - Iwata2009 ER - TY - JOUR AU - Inoue, N. AU - Kobayashi, K. AU - Naganuma, M. AU - Hirai, F. AU - Ozawa, M. AU - Arikan, D. PY - 2017 DA - 2017// TI - Long-term safety and efficacy of adalimumab for intestinal Behçet’s disease in the open label study following a phase 3 clinical trial JO - Intest Res VL - 15 UR - https://doi.org/10.5217/ir.2017.15.3.395 DO - 10.5217/ir.2017.15.3.395 ID - Inoue2017 ER - TY - JOUR AU - Hibi, T. AU - Hirohata, S. AU - Kikuchi, H. AU - Tateishi, U. AU - Sato, N. AU - Ozaki, K. PY - 2016 DA - 2016// TI - Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study JO - Medicine (Baltimore) VL - 95 UR - https://doi.org/10.1097/MD.0000000000003863 DO - 10.1097/MD.0000000000003863 ID - Hibi2016 ER - TY - JOUR AU - Tanida, S. AU - Inoue, N. AU - Kobayashi, K. AU - Naganuma, M. AU - Hirai, F. AU - Iizuka, B. PY - 2015 DA - 2015// TI - Adalimumab for the treatment of Japanese patients with intestinal Behçet’s disease JO - Clin Gastroenterol Hepatol VL - 13 UR - https://doi.org/10.1016/j.cgh.2014.08.042 DO - 10.1016/j.cgh.2014.08.042 ID - Tanida2015 ER - TY - JOUR AU - Lee, J. H. AU - Cheon, J. H. AU - Jeon, S. W. AU - Ye, B. D. AU - Yang, S. K. AU - Kim, Y. H. PY - 2013 DA - 2013// TI - Efficacy of infliximab in intestinal Behçet’s disease: a Korean multicenter retrospective study JO - Inflamm Bowel Dis VL - 19 ID - Lee2013 ER - TY - JOUR AU - Vallet, H. AU - Riviere, S. AU - Sanna, A. AU - Deroux, A. AU - Moulis, G. AU - Addimanda, O. PY - 2015 DA - 2015// TI - Efficacy of anti-TNF alpha in severe and/or refractory Behçet’s disease: multicenter study of 124 patients JO - J Autoimmun VL - 62 UR - https://doi.org/10.1016/j.jaut.2015.06.005 DO - 10.1016/j.jaut.2015.06.005 ID - Vallet2015 ER - TY - JOUR AU - Hisamatsu, T. AU - Ueno, F. AU - Matsumoto, T. AU - Kobayashi, K. AU - Koganei, K. AU - Kunisaki, R. PY - 2014 DA - 2014// TI - The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies JO - J Gastroenterol VL - 49 UR - https://doi.org/10.1007/s00535-013-0872-4 DO - 10.1007/s00535-013-0872-4 ID - Hisamatsu2014 ER - TY - JOUR AU - Lee, H. W. AU - Kim, W. H. AU - Cheon, J. H. PY - 2013 DA - 2013// TI - The medical treatments of intestinal Behcet’s disease: an update JO - Intest Res VL - 11 UR - https://doi.org/10.5217/ir.2013.11.3.155 DO - 10.5217/ir.2013.11.3.155 ID - Lee2013 ER - TY - JOUR AU - Park, Y. E. AU - Cheon, J. H. PY - 2018 DA - 2018// TI - Updated treatment strategies for intestinal Behçet’s disease JO - Korean J Intern Med VL - 33 UR - https://doi.org/10.3904/kjim.2017.377 DO - 10.3904/kjim.2017.377 ID - Park2018 ER - TY - JOUR AU - Cheon, J. H. AU - Han, D. S. AU - Park, J. Y. AU - Ye, B. D. AU - Jung, S. A. AU - Park, Y. S. e. a. PY - 2011 DA - 2011// TI - Development, validation, and respomsiveness of a novel disease activity index for intestinal Behcet’s disease JO - Inflamm Bowel Dis VL - 17 UR - https://doi.org/10.1002/ibd.21313 DO - 10.1002/ibd.21313 ID - Cheon2011 ER - TY - JOUR AU - Lee, H. J. AU - Kim, Y. N. AU - Jang, H. W. AU - Jeon, H. H. AU - Jung, E. S. AU - Park, S. J. PY - 2012 DA - 2012// TI - Correlations between endoscopic and clinical disease activity indices in intestinal Behcet’s disease JO - World J Gastroenterol VL - 28 UR - https://doi.org/10.3748/wjg.v18.i40.5771 DO - 10.3748/wjg.v18.i40.5771 ID - Lee2012 ER - TY - JOUR AU - Suzuki Kurokawa, M. AU - Suzuki, N. PY - 2004 DA - 2004// TI - Behcet’s disease JO - Clin Exp Med VL - 4 UR - https://doi.org/10.1007/s10238-004-0033-4 DO - 10.1007/s10238-004-0033-4 ID - Suzuki Kurokawa2004 ER - TY - STD TI - [No author listed]. Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 1990;335:1078–1080. ID - ref15 ER - TY - JOUR AU - Jung, Y. S. AU - Yoon, J. Y. AU - Lee, J. H. AU - Jeon, S. M. AU - Hong, S. P. AU - Kim, T. I. PY - 2011 DA - 2011// TI - Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease JO - Inflamm Bowel Dis VL - 17 UR - https://doi.org/10.1002/ibd.21517 DO - 10.1002/ibd.21517 ID - Jung2011 ER - TY - JOUR AU - Narum, S. AU - Westergren, T. AU - Klemp, M. PY - 2014 DA - 2014// TI - Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis JO - BMJ Open VL - 4 UR - https://doi.org/10.1136/bmjopen-2013-004587 DO - 10.1136/bmjopen-2013-004587 ID - Narum2014 ER - TY - JOUR AU - Park, J. AU - Cheon, J. H. AU - Park, Y. E. AU - Lee, Y. J. AU - Lee, H. J. AU - Park, S. J. PY - 2017 DA - 2017// TI - Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behcet’s disease JO - Int J Color Dis VL - 32 UR - https://doi.org/10.1007/s00384-016-2728-x DO - 10.1007/s00384-016-2728-x ID - Park2017 ER -